<unk>  is an antimalarial that is FDA approved for the prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported.
Treatment of acute, uncomplicated P. falciparum malaria.   Common adverse reactions include diarrhea, dreams, oral ulcers, headache, abdominal pain, nausea, vomiting, asthenia, anorexia, and dizziness.
Atovaquone-Proguanil
Delamanid
Dihydroartemisinin-Piperaquine
Artemether
Chloroquine
Cycloguanil
Piperaquine
Quinine